Navigation Links
Malaria-curing Herb Must Be Carefully Farmed - WHO

The effectiveness of an anti-malarial herbal drug could be damaged by overplanting of the Chinese shrub from which it is derived//, the World Health Organization (WHO) said on Monday.

The artemisia annua (sweet wormwood) shrub must be more carefully farmed to meet a growing global demand and to keep fakes off the market, the United Nations agency said.

Chinese herbalists have used leaves from the shrub to treat malaria for centuries. It is now widely regarded as the best drug to treat the disease.

Not all shrubs yield enough for the malaria-fighting compound artemisinin to be effective against the mosquito-borne disease that kills a person every 30 seconds.

WHO urged governments to work closely with farmers and drug manufacturers to accurately estimate the demand for artemisinin while avoiding over-production that could hurt crop yields.

Workers also need more technical skills to properly extract artemisinin from dried leaves, it said.

"Not all artemisinin meets the required standards to produce quality medicines," the WHO said in guidelines calling for more stringent monitoring of the plant's cultivation and collection.

"The availability of these treatments still falls short of what is needed."

Resistance to conventional anti-malarial drugs such as chloroquine or amodiaquine have triggered great demand for artemisinin therapy which the WHO has recommended since 2001 in combination with other drugs as a malaria cure.

Counterfeit and sub-standard malaria drugs have become a problem in parts of Africa and Asia and the agency said fake malaria drugs had worsened drug resistance to the disease.

Malaria infects between 300 million and 500 million people each year, killing over 1 million of them, according to WHO. About 90 percent of malaria deaths occur in sub-Saharan Africa, with most victims children under the age of five.

Source-Bio-Bio Tech nology
'"/>




Related medicine news :

1. Epilepsy Needs To Be Managed Carefully
2. Carefully Monitored Treatment Can Help Those Who Suffer from Depression
3. Viral Haemorrhagic Septicaemia Attack On Farmed Trout
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... CA (PRWEB) , ... January 19, 2017 , ... Sam ... planning assistance to commercial and residential clients in the California Bay Area, is launching ... heart health in the region. , Heart disease is the primary killer of adult ...
(Date:1/19/2017)... ... January 19, 2017 , ... Attorney Robert “RC” ... consecutive year donated money to the Triumph Over Kid Cancer foundation. Each year, 175,000 ... of those children. James saw firsthand the effect of the critical funding gap for ...
(Date:1/19/2017)... CT (PRWEB) , ... January 19, 2017 , ... Connecticut ... Sang H. Kim, a highly experienced and compassionate dermatologist. Dr. Kim brings an ... center . , “It is with considerable pleasure to welcome back Dr. Kim to ...
(Date:1/19/2017)... ... January 19, 2017 , ... Each ... Surgery Symposium, a conference where hundreds of surgeons from over fifteen different countries ... topics from cosmetic breast augmentation to breast reconstruction for breast cancer ...
(Date:1/18/2017)... ... 18, 2017 , ... From a health perspective, 2017 will clearly be the ... to chronic disease, mental health and general physical well-being. The New York Times suggested ... consider. , For one Charlottesville restaurant, good gut health is clearly on the menu. ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , January 18, 2017 , , Marks E-QURE ... rd distribution agreement, following similar agreements in ... Wound care is $2 5 ... E-QURE Corp. (OTCQB: EQUR), a leader in medical devices for the ... Tech - Médica Equipos Médicos S.A.S. (TeckMedica) in Colombia ...
(Date:1/19/2017)... , Jan. 18, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
(Date:1/19/2017)... , Jan. 18, 2017   Synthetic ... clinical company developing therapeutics designed to preserve the ... patients, today confirmed plans to initiate a Phase ... modified-release reformulation of lovastatin lactone designed to reduce ... in the gut to treat the underlying ...
Breaking Medicine Technology: